preclinical study

July 9, 2018

Prostreat Seen as Better Than Current Therapies at Stopping Aggressive Prostate Cancer in Mice

News

NucleoBio’s investigative therapy Prostreat was seen to be better at preventing the growth and spread of metastatic castration-resistant prostate cancer than currently available hormone therapies, a mouse study showed. The ... Read more

June 21, 2017

Mechanism Identified in Cellular Change Driving Castration-Resistant Prostate Cancer

News

Researchers at Moffitt Cancer Center have revealed the mechanism that explains the transformation process of prostate cells into castration-resistant cancer cells. They’ve also identified a new drug candidate that targets ... Read more

October 20, 2014October 20, 2014

Testosterone Replacement Therapy Drives Prostate Tumors in Rats

News

A study from a group of researchers at the University of Illinois in Chicago suggests testosterone replacement therapy (TRT) such as implants and injections, can increase the risk of developing prostate cancer, which ... Read more